These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2491359

  • 1. Clinical experience with omeprazole: assessment of efficacy and safety.
    Walan A.
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility and safety of omeprazole.
    Walan A.
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
    [Abstract] [Full Text] [Related]

  • 3. [Omeprazole in the therapy of acid-induced diseases].
    Simon B, Dammann HG, Müller P.
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [Abstract] [Full Text] [Related]

  • 4. The clinical utility and safety of omeprazole.
    Walan A.
    Scand J Gastroenterol Suppl; 1989 Aug; 166():140-4; discussion 145. PubMed ID: 2574908
    [Abstract] [Full Text] [Related]

  • 5. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S, Långström G, Rikner L, Carlsson R, Naesdal J.
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [Abstract] [Full Text] [Related]

  • 6. Omeprazole: a comprehensive review.
    Massoomi F, Savage J, Destache CJ.
    Pharmacotherapy; 1993 May; 13(1):46-59. PubMed ID: 8437967
    [Abstract] [Full Text] [Related]

  • 7. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB, Faulds D, McTavish D.
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [Abstract] [Full Text] [Related]

  • 8. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Aug; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 9. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D, Buckley MM, Heel RC.
    Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Jul; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 13. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E.
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP, Campoli-Richards DM.
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Omeprazole. Its pharmacology and therapeutic efficacy].
    Protzer U, Holtermüller KH.
    Dtsch Med Wochenschr; 1993 Feb 19; 118(7):230-9. PubMed ID: 8440164
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Therapeutic achlorhydria: for which diseases, when and for how long?].
    Koop H, Arnold R.
    Dtsch Med Wochenschr; 1988 Mar 31; 113(13):516-8. PubMed ID: 2894969
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.